Biotin anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_Biotin_042706
C57BL/6 mouse bone marrow cells were stained with biotinylated CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by Sav-PE (gated on total cells).
  • M1slash70_Biotin_042706
    C57BL/6 mouse bone marrow cells were stained with biotinylated CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by Sav-PE (gated on total cells).
Cat # Size Price Quantity Check Availability Save
101203 50 µg 34€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101204 500 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse,Human,Cynomolgus,Rhesus
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  2. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  3. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  4. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  5. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  6. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  7. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  8. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  9. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  10. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  11. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  12. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  13. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  14. Yrlid U, et al. 2019. J Leukoc Biol. 105:195. PubMed
  15. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  16. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  17. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  18. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  19. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  20. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  21. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  22. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  23. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  24. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  25. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  26. Vural A, et al. 2019. J Immunol. 202:1510. PubMed
  27. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  28. Leyva‐Castillo JM et al. 2019. Immunity. 50(5):1262-1275 . PubMed
  29. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  30. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  31. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  32. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  33. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  34. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  35. Bian Y, et al. 2017. PLoS Pathog. 13:e1006384. PubMed
  36. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  37. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  38. Thierry GR, et al. 2018. J Exp Med. 215:2972. PubMed
  39. Stofkova A, et al. 2019. Sci Rep. 2.009027778. PubMed
  40. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  41. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  42. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  43. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  44. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  45. Chen Z, et al. 2020. Cell Death Dis. 11:180. PubMed
  46. De Micheli AJ, et al. 2020. Cell Rep. 30:3583. PubMed
  47. Au-Yeung BB, et al. 2017. J Immunol. 198:2445. PubMed
  48. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  49. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  50. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  51. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  52. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  53. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  54. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  55. Chou H, et al. 2011. Hepatology. 53:1007. PubMed
  56. Ochiai S, et al. 2014. J Immunol. 193:2504. PubMed
  57. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  58. Elsner R, et al. 2015. PLoS Pathog. 10: 1004976. PubMed
  59. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  60. Tsuzuki S, et al. 2015. Int Immunol. 10.1093/intimm/dxv058. PubMed
  61. Periasamy S, et al. 2016. PLoS Pathog. 12: 1005517. PubMed
  62. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  63. Van de Velde L, et al. 2016. Cell Rep. 17:2247-2258. PubMed
  64. Carr M, et al. 2016. Proc Natl Acad Sci U S A. 113(52):15024-15029. PubMed
  65. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  66. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  67. Köchl R, et al. 2020. Elife. 9:00. PubMed
  68. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  69. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  70. Frohlich J, et al. 2020. Aging (Albany NY). 12:20024. PubMed
  71. Ben C, et al. 2020. J Biol Chem. 295:13965. PubMed
  72. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  73. Matson CA, et al. 2020. Proc Natl Acad Sci U S A. 117:14342. PubMed
  74. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  75. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  76. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  77. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  78. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  79. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  80. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  81. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  82. Young K, et al. 2021. Cell Stem Cell. . PubMed
  83. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  84. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  85. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  86. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  87. Rohrbeck L, et al. 2020. Immunol Cell Biol. . PubMed
  88. Ma C, et al. 2021. J Exp Med. :218. PubMed
  89. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  90. Teng Y, et al. 2021. Mol Ther. 29:2424. PubMed
  91. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  92. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  93. Yokozeki Y, et al. 2021. BMC Musculoskelet Disord. 22:634. PubMed
  94. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  95. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  96. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  97. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  98. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  99. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  100. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  101. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  102. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  103. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  104. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  105. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  106. Koide S, et al. 2022. iScience. 25:103603. PubMed
  107. Wang Y, et al. 2022. Front Immunol. 12:809896. PubMed
  108. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  109. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  110. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  111. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  112. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  113. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  114. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  115. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  116. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  117. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  118. Liu G, et al. 2022. Ann Transl Med. 10:693. PubMed
  119. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  120. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  121. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  122. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  123. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  124. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  125. Stofkova A, et al. 2021. Int J Mol Sci. 23:. PubMed
  126. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  127. Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed
  128. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  129. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  130. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  131. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  132. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  133. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  134. Helfen A, et al. 2022. Neoplasia. 28:100792. PubMed
  135. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  136. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  137. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  138. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  139. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  140. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  141. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  142. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  143. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  144. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  145. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  146. Li S, et al. 2022. Elife. 11:. PubMed
  147. McGee MC, et al. 2022. Bio Protoc. 12:. PubMed
  148. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  149. García-Hernández ML, et al. 2022. Front Immunol. 13:1026574. PubMed
  150. Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed
RRID
AB_312786 (BioLegend Cat. No. 101203)
AB_312787 (BioLegend Cat. No. 101204)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.
Go To Top Version: 1    Revision Date: 11-30-2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account